Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 30 Rectal Neoplasms 21 Esophageal Neoplasms 15 Colorectal Neoplasms 15 Pancreatic Neoplasms 12 Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Prostatic Neoplasms 10 Adenocarcinoma Of Esophagus 9 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Head and Neck Neoplasms 8 Sarcoma 7 Esophageal Squamous Cell Carcinoma 7 Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Urinary Bladder Neoplasms 4 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Breast Neoplasms, Male 4 Breast Carcinoma In Situ 4 Brain Neoplasms 4 Recurrence 3 Neoplasm Metastasis 3 Kidney Neoplasms 3 Glioma 3 Glioblastoma 3

Interventions

Gemcitabine 27 Fluorouracil 25 Oxaliplatin 21 Cisplatin 19 Leucovorin 17 Bevacizumab 15 130-nm albumin-bound paclitaxel 13 Docetaxel 12 Capecitabine 12 Albumin-Bound Paclitaxel 12 Paclitaxel 11 Irinotecan 10 Carboplatin 9 pembrolizumab 7 Radiotherapy 6 Pemetrexed 6 Nivolumab 6 Erlotinib Hydrochloride 6 Cyclophosphamide 6 Trastuzumab 5 Ramucirumab 5 Ipilimumab 4 Everolimus 4 Crizotinib 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Neoadjuvant Therapy × Clear all

NCT01521702 2015-03-20

NEOPAC

Institut Paoli-Calmettes

Phase 3 Completed

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡